<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Murabito JM</submitter><funding>NCRR NIH HHS</funding><funding>NHLBI NIH HHS</funding><pagination>S6</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC1995609</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>8 Suppl 1</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Breast and prostate cancer are two commonly diagnosed cancers in the United States. Prior work suggests that cancer causing genes and cancer susceptibility genes can be identified.&lt;h4>Methods&lt;/h4>We conducted a genome-wide association study (Affymetrix 100K SNP GeneChip) of cancer in the community-based Framingham Heart Study. We report on 2 cancer traits--prostate cancer and breast cancer--in up to 1335 participants from 330 families (54% women, mean entry age 33 years). Multivariable-adjusted residuals, computed using Cox proportional hazards models, were tested for association with qualifying SNPs (70, 987 autosomal SNPs with genotypic call rate > or =80%, minor allele frequency > or =10%, Hardy-Weinberg test p > or = 0.001) using generalized estimating equations (GEE) models and family based association tests (FBAT).&lt;h4>Results&lt;/h4>There were 58 women with breast cancer and 59 men with prostate cancer. No SNP associations attained genome-wide significance. The top SNP associations in GEE models for each trait were as follows: breast cancer, rs2075555, p = 8.0 x 10(-8) in COL1A1; and prostate cancer, rs9311171, p = 1.75 x 10(-6) in CTDSPL. In analysis of selected candidate cancer susceptibility genes, two MSR1 SNPs (rs9325782, GEE p = 0.008 and rs2410373, FBAT p = 0.021) were associated with prostate cancer and three ERBB4 SNPs (rs905883 GEE p = 0.0002, rs7564590 GEE p = 0.003, rs7558615 GEE p = 0.0078) were associated with breast cancer. The previously reported risk SNP for prostate cancer, rs1447295, was not included on the 100K chip. Results of cancer phenotype-genotype associations for all autosomal SNPs are web posted at http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007 webcite.&lt;h4>Conclusion&lt;/h4>Although no association attained genome-wide significance, several interesting associations emerged for breast and prostate cancer. These findings can serve as a resource for replication in other populations to identify novel biologic pathways contributing to cancer susceptibility.</pubmed_abstract><journal>BMC medical genetics</journal><pubmed_title>A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.</pubmed_title><pmcid>PMC1995609</pmcid><funding_grant_id>N01-HC-25195</funding_grant_id><funding_grant_id>1S10RR163736-01A1</funding_grant_id><pubmed_authors>Murabito JM</pubmed_authors><pubmed_authors>Hwang SJ</pubmed_authors><pubmed_authors>Rosenberg CL</pubmed_authors><pubmed_authors>Kreger BE</pubmed_authors><pubmed_authors>Levy D</pubmed_authors><pubmed_authors>Antman K</pubmed_authors><pubmed_authors>Finger D</pubmed_authors><pubmed_authors>Splansky GL</pubmed_authors></additional><is_claimable>false</is_claimable><name>A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.</name><description>&lt;h4>Background&lt;/h4>Breast and prostate cancer are two commonly diagnosed cancers in the United States. Prior work suggests that cancer causing genes and cancer susceptibility genes can be identified.&lt;h4>Methods&lt;/h4>We conducted a genome-wide association study (Affymetrix 100K SNP GeneChip) of cancer in the community-based Framingham Heart Study. We report on 2 cancer traits--prostate cancer and breast cancer--in up to 1335 participants from 330 families (54% women, mean entry age 33 years). Multivariable-adjusted residuals, computed using Cox proportional hazards models, were tested for association with qualifying SNPs (70, 987 autosomal SNPs with genotypic call rate > or =80%, minor allele frequency > or =10%, Hardy-Weinberg test p > or = 0.001) using generalized estimating equations (GEE) models and family based association tests (FBAT).&lt;h4>Results&lt;/h4>There were 58 women with breast cancer and 59 men with prostate cancer. No SNP associations attained genome-wide significance. The top SNP associations in GEE models for each trait were as follows: breast cancer, rs2075555, p = 8.0 x 10(-8) in COL1A1; and prostate cancer, rs9311171, p = 1.75 x 10(-6) in CTDSPL. In analysis of selected candidate cancer susceptibility genes, two MSR1 SNPs (rs9325782, GEE p = 0.008 and rs2410373, FBAT p = 0.021) were associated with prostate cancer and three ERBB4 SNPs (rs905883 GEE p = 0.0002, rs7564590 GEE p = 0.003, rs7558615 GEE p = 0.0078) were associated with breast cancer. The previously reported risk SNP for prostate cancer, rs1447295, was not included on the 100K chip. Results of cancer phenotype-genotype associations for all autosomal SNPs are web posted at http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?id=phs000007 webcite.&lt;h4>Conclusion&lt;/h4>Although no association attained genome-wide significance, several interesting associations emerged for breast and prostate cancer. These findings can serve as a resource for replication in other populations to identify novel biologic pathways contributing to cancer susceptibility.</description><dates><release>2007-01-01T00:00:00Z</release><publication>2007 Sep</publication><modification>2026-04-13T13:14:16.291Z</modification><creation>2026-04-07T13:29:52.422Z</creation></dates><accession>S-EPMC1995609</accession><cross_references><pubmed>17903305</pubmed><doi>10.1186/1471-2350-8-S1-S6</doi></cross_references></HashMap>